GALIA FELICIANO: Open Payments
NPI 1174159552 · FREDERICKSBRG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 18 payments from 12 companies in 2025. Trend: 2023 $95 · 2024 $290 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $150 |
| Exact Sciences Corporation | 3 | $131 |
| Lilly USA, LLC | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 1 | $47 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| ViiV Healthcare Company | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| CooperSurgical, Inc. | 1 | $19 |
Products named: Wegovy, The Cologuard Plus Collection Kit, ZEPBOUND, KEVEYIS, Cologuard Collection Kit, Veozah, QULIPTA, APRETUDE.
Industry payments across VA — which companies pay providers there.
